Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.800
+0.040 (2.27%)
At close: Nov 7, 2025, 4:00 PM EST
1.830
+0.030 (1.67%)
After-hours: Nov 7, 2025, 7:07 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Rare Disease Therapies
12.43M